The effectiveness of compulsory drug treatment: A systematic review

International Journal of Drug Policy

Volumn 28, Issue , 2016, Pages 1-9

  Werb, D ^a,b   Kamarulzaman, A ^c   Meacham, M C ^b   Rafful, C ^b   Fischer, B ^d   Strathdee, S A ^b   Wood, E ^a,b,e  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF MALAYA   (Malaysia)

^d CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^e BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

Author keywords

Addiction; Compulsory treatment; Global; Policy; Systematic review

Indexed keywords

CLINICAL EFFECTIVENESS; COMMUNITY BASED TREATMENT; COMPULSORY DRUG TREATMENT; COUNSELING; CRIMINAL RECIDIVISM; DRUG DEPENDENCE; DRUG DETENTION FACILITY; DRUG DETOXIFICATION; DRUG THERAPY; DRUG USE; DRUG WITHDRAWAL; EVIDENCE BASED MEDICINE; GOVERNMENT REGULATION; GROUP BASED OUTPATIENT TREATMENT; HEALTH CARE FACILITY; HEALTH CARE POLICY; HIGH RISK POPULATION; HUMAN; INJECTION DRUG USE; LAW; LEGAL ASPECT; LONG TERM INPATIENT TREATMENT; OUTCOME ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL; PRISON BASED TREATMENT; PSYCHOLOGICAL COUNSELING; PUBLISHING; QUALITY CONTROL; RESOURCE ALLOCATION; SHORT SURVEY; SHORT TERM INPATIENT TREATMENT; SYSTEMATIC REVIEW; MANDATORY PROGRAM; PROGRAM EVALUATION; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

HUMANS; MANDATORY PROGRAMS; PROGRAM EVALUATION; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 84958124578     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2015.12.005     Document Type: Short Survey

References (66)

1. UNODC World drug report 2015 2015, United Nations Office on Drugs and Crime, Vienna.
2. Degenhardt L., Whiteford H.A., Ferrari A.J., Baxter A.J., Charlson F.J., Hall W.D., et al. Global burden of disease attributable to illicit drug use and dependence: Findings from the Global Burden of Disease Study 2010. The Lancet 2013, 382(9904):1564-1574.
3. Jurgens R. Effectiveness of interventions to address HIV in prisons 2007, World Health Organization (WHO), United Nations Office on Drugs and Crime (UNODC), and Joint United Nations Programme on HIV/AIDS (UNAIDS), Geneva.
4. Mattick R.P., Breen C., Kimber J., Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Reviews 2009, 2:CD002209.
5. Amato L., Davoli M., Ferri M., Ali R. Methadone at tapered doses for the management of opioid withdrawal. Cochrane Database of Systematic Reviews 2002, 1:CD003409.
6. Gowing L., Ali R., White J. Buprenorphine for the management of opioid withdrawal. Cochrane Database of Systematic Reviews 2004, 4.
7. As S., Young J., Vieira K. Long-term suboxone treatment and its benefit on long-term remission for opiate dependence. Journal of Psychiatry 2014, 17(1000174):2.
8. Krupitsky E., Nunes E.V., Ling W., Illeperuma A., Gastfriend D.R., Silverman B.L. Injectable extended-release naltrexone for opioid dependence: A double-blind, placebo-controlled, multicentre randomised trial. Lancet 2011, 377(9776):1506-1513.
9. Wolfe D., Carrieri M.P., Dasgupta N., Wodak A., Newman R., Bruce R.D. Concerns about injectable naltrexone for opioid dependence. Lancet 2011, 377(9776):1468-1470.
10. Ferri M., Davoli M., Perucci C.A. Pharmaceutical heroin for heroin maintenance in chronic heroin dependents. Cochrane Database of Systematic Reviews 2011, 12.
11. Castells X., Casas M., Perez-Maña C., Roncero C., Vidal X., Capellà D. Efficacy of psychostimulant drugs for cocaine dependence. Cochrane Database of Systematic Reviews 2010, 2.
12. Fischer B., Blanken P., Da Silveira D., Gallassi A., Goldner E.M., Rehm J., et al. Effectiveness of secondary prevention and treatment interventions for crack-cocaine abuse: A comprehensive narrative overview of English-language studies. International Journal of Drug Policy 2015.
13. Shearer J., Wodak A., Van Beek I., Mattick R.P., Lewis J. Pilot randomized double blind placebo-controlled study of dexamphetamine for cocaine dependence. Addiction 2003, 98(8):1137-1141.
14. Mooney M.E., Herin D.V., Schmitz J.M., Moukaddam N., Green C.E., Grabowski J. Effects of oral methamphetamine on cocaine use: A randomized, double-blind, placebo-controlled trial. Drug and Alcohol Dependence 2009, 101(1):34-41.
15. Grabowski J., Rhoades H., Schmitz J., Stotts A., Daruzska L.A., Creson D., et al. Dextroamphetamine for cocaine-dependence treatment: A double-blind randomized clinical trial. Journal of Clinical Psychopharmacology 2001, 21(5):522-526.
16. Hofmann S.G., Asnaani A., Vonk I.J., Sawyer A.T., Fang A. The efficacy of cognitive behavioral therapy: A review of meta-analyses. Cognitive Therapy and Research 2012, 36(5):427-440.
17. Dutra L., Stathopoulou G., Basden S.L., Leyro T.M., Powers M.B., Otto M.W. A meta-analytic review of psychosocial interventions for substance use disorders. American Journal of Psychiatry 2008, 165(2):179-187.
18. Prendergast M., Podus D., Finney J., Greenwell L., Roll J. Contingency management for treatment of substance use disorders: A meta-analysis. Addiction 2006, 101(11):1546-1560.
19. Israelsson M., Gerdner A. Compulsory commitment to care of substance misusers: International trends during 25 years. European Addiction Research 2011, 18(6):302-321.
20. Wild T.C. Compulsory substance-user treatment and harm reduction: A critical analysis. Substance Use & Misuse 1999, 34(1):83-102.
21. Hiller M.L., Knight K., Broome K.M., Simpson D.D. Compulsory community-based substance abuse treatment and the mentally ill criminal offender. The Prison Journal 1996, 76(2):180-191.
22. WHO Regional Office for the Western Pacific Assessment of compulsory treatment of people who use drugs in Cambodia, China, Malaysia and Viet Nam: Application of selected human rights principles 2009, World Health Organization, Geneva.
23. Bright D.A., Martire K.A. Does coerced treatment of substance-using offenders lead to improvements in substance use and recidivism? A review of the treatment efficacy literature. Australian Psychologist 2012.
24. Werb D., Elliott R., Fischer B., Wood E., Montaner J., Kerr T. Drug treatment courts in Canada: An evidence-based review. HIV/AIDS Policy & Law Review 2007, 12(2/3):6.
25. Hall W., Babor T., Edwards G., Laranjeira R., Marsden J., Miller P., et al. Compulsory detention, forced detoxification and enforced labour are not ethically acceptable or effective ways to treat addiction. Addiction 2012, 107(11):1891-1893.
26. Jurgens R., Csete J. In the name of treatment: Ending abuses in compulsory drug detention centers. Addiction 2012, 107(4):689-691.
27. Wild T.C., Roberts A.B., Cooper E.L. Compulsory substance abuse treatment: An overview of recent findings and issues. European Addiction Research 2002, 8(2):84-93.
28. Stevens A., Berto D., Heckmann W., Kerschl V., Oeuvray K., van Ooyen M., et al. Quasi-compulsory treatment of drug dependent offenders: An international literature review. Substance Use & Misuse 2005, 40(3):269-283.
29. Amon J.J., Pearshouse R., Cohen J., Schleifer R. Compulsory drug detention centers in China, Cambodia, Vietnam, and Laos: Health and human rights abuses. Health and Human Rights 2013, 15(2).
30. Malta M., Beyrer C. The HIV epidemic and human rights violations in Brazil. Journal of International AIDS Society 2013, 16(1).
31. Birgden A., Grant L. Establishing a compulsory drug treatment prison: Therapeutic policy, principles, and practices in addressing offender rights and rehabilitation. International Journal of Law and Psychiatry 2010, 33(5):341-349.
32. Hall W., Carter A. Advocates need to show compulsory treatment of opioid dependence is effective, safe and ethical. Bulletin of the World Health Organization 2013, 91(2):146.
33. Pearshouse R. "Patients, not criminals"? An assessment of Thailand's compulsory drug dependence treatment system. HIV/AIDS Policy & Law Review/Canadian HIV/AIDS Legal Network 2009, 14(1):11.
34. Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ 2009, 339:b2535.
35. Downs S.H., Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. Journal of Epidemiology and Community Health 1998, 52(6):377-384.
36. Sun B., Ye Y., Qin L. An analysis of relapse factors of 615 heroin addicts. Chinese Journal of Drug Dependence 2001, 10(3):214-216.
37. Kelly J., Finney J., Moos R. Substance use disorder patients who are mandated to treatment: Characteristics, treatment process, and 1-and 5-year outcomes. Journal of Substance Abuse Treatment 2005, 28(3):213-223.
38. Fairbairn N., Hayashi K., Ti L., et al. Compulsory drug detention and injection drug use cessation and relapse in Bangkok, Thailand. Drug and Alcohol Review 2014.
39. Jansson I., Hesse M., Fridell M. Influence of personality disorder features on social functioning in substance-abusing women five years after compulsive residential treatment. European Addiction Research 2008, 15(1):25-31.
40. Strauss S., Falkin G. The first week after drug treatment: The influence of treatment on drug use among women offenders. American Journal of Drug and Alcohol Abuse 2001, 27(2):241-264.
41. Huang K., Zhang L., Liu J. Drug problems in contemporary China: A profile of Chinese drug users in a metropolitan area. International Journal of Drug Policy 2011, 22(2):128-132.
42. Vaughn M., Deng F., Lee L.-J. Evaluating a prison-based drug treatment program in Taiwan. Journal of Drug Issues 2003, 33(2):357-383.
43. Hiller M., Knight K., Simpson D. Recidivism following mandated residential substance abuse treatment for felony probationers. The Prison Journal 2006, 86(2):230-241.
44. Ouimette P.C., Finney J.W., Moos R.H. Twelve-step and cognitive-behavioral treatment for substance abuse a comparison of treatment effectiveness. Journal of Consulting and Clinical Psychology 1997, 65(2):230-240.
45. Pearshouse R. Compulsory drug treatment in Thailand: Observations on the Narcotic Addict Rehabilitation Act BE 2545 (2002) 2009, Canadian HIV/AIDS Legal Network, Toronto.
46. Rengifo A.F., Stemen D. The impact of drug treatment on recidivism: Do mandatory programs make a difference? Evidence from Kansas's Senate Bill 123. Crime & Delinquency 2010.
47. Utyasheva L. Russian Federation: Inhumane conditions in drug treatment facilities lead to tragedy. HIV/AIDS Policy & Law Review 2007, 12(1):32-33.
48. Mendelevich V.D. Bioethical differences between drug addiction treatment professionals inside and outside the Russian Federation. Harm Reduction Journal 2011, 8(1):15.
49. CNN Vecinos del centro de rehabilitación 'Fe y Vida' cuentan lo que escucharon 2010, CNN, Mexico.
50. ILO Joint statement on compulsory drug detention and rehabilitation centres ILO, OHCHR, UNDP, UNESCO, UNFPA, UNHCR, UNICEF, UNODC, UN Women, WFP, WHO and UNAIDS 2012, United Nations Office of the High Commissioner for Human Rights, Geneva.
51. Qian H.Z., Hao C., Ruan Y., Cassell H.M., Chen K., Qin G., et al. Impact of methadone on drug use and risky sex in China. Journal of Substance Abuse Treatment 2008, 34(4):391-397.
52. Sullivan S.G., Wu Z. Rapid scale up of harm reduction in China. International Journal of Drug Policy 2007, 18(2):118-128.
53. Wu Z., Sullivan S.G., Wang Y., Rotheram-Borus M.J., Detels R. Evolution of China's response to HIV/AIDS. Lancet 2007, 369(9562):679-690.
54. Baharom N., Hassan M.R., Ali N., Shah S.A. Improvement of quality of life following 6 months of methadone maintenance therapy in Malaysia. Substance Abuse Treatment, Prevention, and Policy 2012, 7(1):32.
55. Reid G., Kamarulzaman A., Sran S.K. Malaysia and harm reduction: The challenges and responses. International Journal of Drug Policy 2007, 18(2):136-140.
56. Hammett T.M., Wu Z., Duc T.T., Stephens D., Sullivan S., Liu W., et al. 'Social evils' and harm reduction: The evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam. Addiction 2008, 103(1):137-145.
57. Nguyen T., Nguyen L.T., Pham M.D., Vu H.H., Mulvey K.P. Methadone maintenance therapy in Vietnam: An overview and scaling-up plan. Advances in Preventive Medicine 2012 2012.
58. Yin W., Hao Y., Sun X., Gong X., Li F., Li J., et al. Scaling up the national methadone maintenance treatment program in China: Achievements and challenges. International Journal of Epidemiology 2010, 39(Suppl. 2):ii29-ii37.
59. Larney S., Dolan K. Compulsory detoxification is a major challenge to harm reduction in China. International Journal of Drug Policy 2010, 21(3):165-166.
60. Garcia A. Serenity: Violence, inequality, and recovery on the edge of Mexico City. Medical Anthropology Quarterly 2015.
61. Lozano-Verduzco I., Marín-Navarrete R., Romero-Mendoza M., Tena-Suck A. Experiences of power and violence in Mexican men attending mutual-aid residential centers for addiction treatment. American Journal of Men's Health 2015, pii:1557988314565812.
62. Bluthenthal R.N., Kral A.H., Lorvick J., Watters J.K. Impact of law enforcement on syringe exchange programs: A look at Oakland and San Francisco. Medical Anthropology 1997, 18(1):61.
63. Cooper H., Moore L., Gruskin S., Krieger N. The impact of a police drug crackdown on drug injectors' ability to practice harm reduction: A qualitative study. Social Science & Medicine 2005, 61(3):673-684.
64. Beletsky L., Lozada R., Gaines T., Abramovitz D., Staines H., Vera A., et al. Syringe confiscation as an HIV risk factor: The public health implications of arbitrary policing in Tijuana and Ciudad Juarez, Mexico. Journal of Urban Health 2013, 1-15.
65. Beletsky L., Heller D., Jenness S.M., Neaigus A., Gelpi-Acosta C., Hagan H. Syringe access, syringe sharing, and police encounters among people who inject drugs in New York City: A community-level perspective. International Journal of Drug Policy 2014, 25(1):105-111.
66. Werb D., Wood E., Small W., Strathdee S., Li K., Montaner J., et al. Effects of police confiscation of illicit drugs and syringes among injection drug users in Vancouver. International Journal of Drug Policy 2008, 19(4):332.